Corcept Therapeutics, Inc. (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $22.21 -1.2%
EPS Growth %: +57.1%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +57.1%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.05 million versus the consensus estimate of $2.07 million.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Primis Financial (FRST) Misses Q1 EPS by 8c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
